Closure of Trading Window from 01-04-2026 till 48 hours after the declaration of Audited Financial Results for the year ended 31/03/2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Samrat Pharmachem Ltd has informed BSE that its trading window will remain closed from April 1, 2026, until 48 hours after the declaration of audited financial results for the year ended March 31, 2026. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's internal Code of Conduct. During this period, all designated persons and their immediate relatives are prohibited from buying, selling, or pledging shares of the company. The filing was signed by Nishant Kankaria, Company Secretary and Compliance Officer, on March 25, 2026.
This is a routine regulatory filing ahead of the company's annual results announcement and does not signal any positive or negative business development. Shareholders should note that insider activity will be restricted until the audited results are published, which typically leads to a brief period of lower liquidity from insiders.